Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis

@inproceedings{Kirschner2015Fibulin3LI,
  title={Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis},
  author={Michaela B Kirschner and Emily Pulford and Mir Alireza Hoda and Anita R{\'o}zs{\'a}s and Kim M Griggs and Yuen Yee Cheng and J. James B. Edelman and Steven C. Kao and Rebecca Hyland and Yawen W Dong and Viktoria Laszlo and Thomas Klikovits and Michael Patrick Vallely and Michael Grusch and Bal{\'a}zs Hegedűs and Bal{\'a}zs Dome and Walter Klepetko and Nico van Zandwijk and Sonja Klebe and Glen Reid},
  booktitle={British Journal of Cancer},
  year={2015}
}
Background:Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies.Methods:ELISA was used to measure cellular and secreted FBLN3 in cell lines, in plasma of xenograft tumour-bearing mice, in plasma from two independent series of MPM and non-MPM patients and in pleural fluid from a third series. Diagnostic and prognostic potential of FBLN3 was assessed by receiver operating characteristics curve… CONTINUE READING
Highly Cited
This paper has 27 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

4 Figures & Tables

Topics

Statistics

01020201620172018
Citations per Year

Citation Velocity: 9

Averaging 9 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.